Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients: a nationwide cohort study

Research output: Contribution to journalJournal articlepeer-review

  1. Training Contemporary levels of cardiopulmonary resuscitation training in Denmark

    Research output: Contribution to journalJournal articlepeer-review

  2. Food purchases in households with and without diabetes based on consumer purchase data

    Research output: Contribution to journalJournal articlepeer-review

  3. Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controls

    Research output: Contribution to journalJournal articlepeer-review

  4. Risk of out-of-hospital cardiac arrest in patients with epilepsy and users of antiepileptic drugs

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

OBJECTIVE: To determine whether preoperative staging of high-risk prostate cancer with 18F-sodium-fluoride (18F-NaF) positron emission tomography (PET) reduces the risk of skeletal metastases.

DESIGN: Nationwide, population-based cohort study using real-world data.

SETTING: The study used national health registries, including all sites in Denmark from 2011 to 2018.

PARTICIPANTS: Newly diagnosed high-risk prostate cancer patients who underwent radical prostatectomy from 2011 to 2018. Patients were stratified into two groups according to the preoperative imaging modality of either 18F-NaF PET or bone scintigraphy.

MAIN OUTCOME MEASURES: The risk of skeletal-related events (SREs) as a proxy for skeletal metastases following radical prostatectomy. The secondary endpoint was overall survival.

RESULTS: Between 1 January 2011 and 31 December 2018, 4183 high-risk patients underwent radical prostatectomy. Of these patients, 807 (19.3%) underwent 18F-NaF PET and 2161 (51.7%) underwent bone scintigraphy. The remaining 30% were examined by a different imaging method or did not undergo imaging. Using the inverse probability of treatment weighting to control potential confounding, the HR of experiencing an SRE for patients in the 18F-NaF PET group versus the bone scintigraphy group was 1.15 (95% CI 0.86 to 1.54). The 3-year survival rates were 97.4% (95% CI 96.1 to 98.7) and 97.1% (95% CI 96.4 to 97.9) for patients receiving 18F-NaF PET and bone scintigraphy, respectively.

CONCLUSION: Patients with high-risk prostate cancer undergoing preoperative staging with 18F-NaF PET did not display a lower risk of developing SREs after prostatectomy compared with patients undergoing bone scintigraphy. The survival rates were similar between the two groups.

Original languageEnglish
Article numbere058898
JournalBMJ Open
Volume12
Issue number6
Pages (from-to)e058898
ISSN2044-6055
DOIs
Publication statusPublished - 15 Jun 2022

Bibliographical note

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

    Research areas

  • Bone Neoplasms/diagnostic imaging, Cohort Studies, Fluorine Radioisotopes, Humans, Male, Positron-Emission Tomography/methods, Prostatic Neoplasms/diagnostic imaging, Sodium Fluoride, epidemiology, nuclear medicine, urological tumours, oncology

ID: 78879724